NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE275031 Query DataSets for GSE275031
Status Public on Aug 28, 2024
Title Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an activation of cardiac fibroblast and macrophage subsets. Integration of fibroblasts from HFpEF with two murine models for heart failure with reduced ejection fraction (HFrEF) identified a catalog of conserved fibroblast phenotypes across mouse models. Moreover, HFpEF specific characteristics included induced metabolic, hypoxic and inflammatory transcription factors and pathways, including enhanced expression of Angiopoietin-like 4 (Angptl4) next to basement membrane compounds, such as collagen IV (Col4a1). Fibroblast activation was further dissected into transcriptional and compositional shifts and thereby highly responsive cell states for each HF model were identified. In contrast to HFrEF, where myofibroblast and matrifibrocyte activation were crucial features, we found that these cell states played a subsidiary role in early HFpEF. These disease-specific fibroblast signatures were corroborated in human myocardial bulk transcriptomes. Furthermore, we identified a potential cross-talk between macrophages and fibroblasts via SPP1 and TNFÉ‘ with estimated fibroblast target genes including Col4a1 and Angptl4. Treatment with recombinant ANGPTL4 ameliorated the murine HFpEF phenotype and diastolic dysfunction by reducing collagen IV deposition from fibroblasts in vivo and in vitro. In line, ANGPTL4, was elevated in plasma samples of HFpEF patients and particularly high levels associated with a preserved global longitudinal strain. Taken together, our study provides a comprehensive characterization of molecular fibroblast activation patterns in murine HFpEF, as well as the identification of Angiopoietin-like 4 as central mechanistic regulator with protective effects.
 
Overall design Comparing effects of HFpEF treamtent (L-NAME +HFD) mouse model with control. We sequenced ventricular tissue of 2x control and 2x HFpEF mice.
Web link https://pubmed.ncbi.nlm.nih.gov/39311911/
 
Contributor(s) Leuschner F, Wienecke LM
Citation(s) 39311911
Submission date Aug 16, 2024
Last update date Nov 27, 2024
Contact name Florian Leuschner
Organization name Uni Heidelberg
Street address INF 669
City Heidelberg
ZIP/Postal code 69120
Country Germany
 
Platforms (1)
GPL21626 NextSeq 550 (Mus musculus)
Samples (4)
GSM8464571 control_1
GSM8464572 control_2
GSM8464573 heartfailure_1
Relations
BioProject PRJNA1148991

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE275031_cell_ranger_outs.tar.gz 1.8 Gb (ftp)(http) TAR
GSE275031_integrated_seurat_obj.rds.gz 767.5 Mb (ftp)(http) RDS
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap